A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

Hepatology

Volumn 31, Issue 4, 2000, Pages 864-871

  Malinchoc, Michael ^a   Kamath, Patrick S ^a   Gordon, Fredric D ^b   Peine, Craig J ^c   Rank, Jeffrey ^d   Ter Borg, Pieter C J ^e  

^a MAYO CLINIC   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE;

ACCURACY; ADULT; AGED; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ESOPHAGUS VARICES BLEEDING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL MODEL; SURVIVAL TIME; VALIDATION PROCESS;

EID: 0034106289     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/he.2000.5852     Document Type: Article

References (29)

1. Kamath PS, McKusick MA. Transvenous intrahepatic portosystemic shunts. Gastroenterology 1996;111:1700-1705.
2. Burroughs AK, Hamilton G, Philips A, Mezzanotte G, McIntire N, Hobbs KEF. A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med 1989;321:857-862.
3. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Berarnaug M, Berger E, et al. The transjugular intrahepatic portosystemic stent shunt procedure for variceal bleeding. N Engl J Med 1994;330:165-171.
4. Ochs A, Rossle M, Haag K, Hauenstein KH, Derbert P, Siegersteter V, Huonker M, et al. The transjugular intrahepatic portosystemic stentshunt procedure for refractory ascites. N Engl J Med 1995;332:1192-1197.
5. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffman ML, Tisnado J, Cole P. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996;111:138-146.
6. Patch D, Nikolopoulou V, McCormick A, Dick R, Armonis A, Wannamethee G, Burroughs A. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol 1998;28:454-460.
7. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffman ML, DeMeo J, Cole PE, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112:1040-1043.
8. Jabbour N, Zajko AB, Orons PD, Irish W, Bartoli F, Marsh WJ, Dodd GD 3rd, et al. Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. Liver Transplant Surg 1996;2:139-147.
9. Rouillard SS, Bass NM, Roberts JP, Doherty CA, Geel, Bacchetti P, Somberg KA. Severe hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts: natural history and predictors of outcome. Ann Int Med 1998;128:374-377.
10. Pugh RNH, Murray-Lyon IM, Dawson JL, Pictioni MC, Williams R. Transection of the esophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
11. Conn HO. A peek at the Child-Turcotte classification. HEPATOLOGY 1981;1:673-676.
12. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. HEPATOLOGY 1989;10:1-7.
13. Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, LaRusso NF, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992;103:1893-1901.
14. Everhart JE, Lombardero M, Detre KM, Zetterman RK, Wiesner RH, Lake JR, Hoofnagle JH. Increased waiting time for liver transplantation results in higher mortality. Transplantation 1997;64:1300-1306.
15. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. HEPATOLOGY 1996;23:164-176.
16. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL. Comparison of lactulose and neomycin in the treatment of chronic portosystemic encephalopathy. A double-blind controlled trial. Gastroenterology 1977;72:573-583.
17. Ven der Besselarr AM. Precision and accuracy of the international normalized ratio for prothrombin time in oral anticoagulation control. Hemostasis 1996;26:248-265.
18. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-202. Downton E Discussion. J R Stat Soc [B] 1972;34:202-220.
19. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-202. Downton E Discussion. J R Stat Soc [B] 1972;34:202-220.
20. SAS Institute SAS User's Guide: Volume 1. Cary, North Carolina: SAS Institute, 1989.
21. Statistical Sciences, Inc. S-Plus Reference Manual Version 3.2 Seattle: Stat Sci, A Division of MathSoft, Inc., 1993.
22. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
23. Harrington DP, Fleming TR. A class of rank test procedures for censored survival data. Biometrika 1982;69:553-566.
24. Riordan SM, Williams R. Current concepts. Treatment of hepatic encephalopathy. N Engl J Med 1997;337:473-476.
25. Grahn EP, Dietz AA, Stefani SS. Burr cells, hemolytic anemia and cirrhosis. Am J Med 1968;45:78.
26. Cooper GS, Bellamy P, Dawson NV, Desbiens N. Fulkerson WJ Jr, Goldman L, Quinn LM, et al. A prognostic model for patients with end-stage liver disease. Gastroenterology 1997;113:1278-1288.
27. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995;59:361-365.
28. Sarfeh IJ, Rypins EB, Mason GR. A systematic appraisal of portacaval H-graft diameters. Clinical and Hemodynamic Perspectives. Ann Surg 1986;204:356-363.
29. Somberg KA, Lombardero MS, Lawlor SM, Ascher NL, Lake JR, Wiesner RH, Zetterman RK. A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database. Transplantation 1997;63:1074-1079.